Roche to pay $250M for Good Therapeutics and its targeted drug technology Biopharmadive Sep 7, 2022 Media
Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program MedCityNews Sep 7, 2022 Media
Roche to acquire Good Therapeutics’ lead drug program for $250M, plus milestone payments GeekWire Sep 7, 2022 Media